Adverse reactions in connection with zimeldine treatment--a review.
The results of clinical trials have shown that the general level of side-effects is substantially lower with zimeldine than with tricyclic antidepressants. Data from ordinary clinical usage in Sweden and the U.K. (as opposed to clinical research experience) shows a similar picture. Hypersensitivity reactions, characterized by fever, myalgia and/or arthralgia, and transient increases in transaminases, occur in approximately 1.5% of patients. In rare cases potentially serious neuropathies have been reported.
D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D013548:Sweden; D006113:United Kingdom; D015031:Zimeldine / Q000009:adverse effects*
D015031:Zimeldine